Skip to main content
PAS 2024 Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Pre-Conference Ticketed Event
Pre-Conference Ticketed Event
APA Award Winner
APA Award Winner
APS Award Winner
APS Award Winner
ASPN Award Winner
ASPN Award Winner
SPR Award Winner
SPR Award Winner
On Demand Presentation
On Demand Presentation
Poster Icons
SPR Award Winner
SPR Award Winner
Back
Evaluation ViewAttendees 48
Hot Topic Symposia

Adolescent Medicine

Basic Science

Clinical Research

General Pediatrics

Injury Prevention

Mental Health

Neurology

Public Health
Session Type: Hot Topic Symposia

Children, Youth, and Cannabis: What Does the Evidence Say?

Sunday, May 5, 2024
2:00 PM – 3:30 PM ET
Location: Metro Toronto Convention Centre: 718 A
CE: Live CME: 1.5

Selected By: AACAP
Co-sponsored By: SAHM
Disclosure(s):
Amy Yule, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Evangelia Lila Amirali, MD, FRCPC, DFAPA, MMGMT (IMHL): JANSSEN (Terminated, April 30, 2022) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness); Lundbeck (Terminated, May 30, 2022) (Products/Services: Advisory Committee); TAKEDA (Terminated, February 12, 2022) (Products/Services: Advisory Committee)

Session

Description: In 2012 Colorado and Washington State became the first states in the North America to legalize non-medical cannabis for adult use. Canada subsequently legalized non-medical cannabis for adults in 2018, and an additional 19 states within the United States and the District of Columbia have followed suit as of March 2023. With legalization and acceptability propelled by popular/social media, youth and parent perception of risk associated with cannabis use has decreased, and cannabis use among adolescents has stayed stable despite the decreased prevalence of other substance use among youth in the United States. Subsequently, unexpected harms have surfaced, e.g., high rate of poisoning hospitalizations and impacts on mental health among children. This hot topic session will focus on the scientific evidence of the health impacts of cannabis legalization and exposure on children and youth. Dr. Patricia Conrod will review evidence regarding the relationship between cannabis and adolescent brain health. Dr. Lila Amirali will review the association between cannabis use and psychosis. She will also review trends in the prevalence of cannabis-induced psychosis and co-occurring schizophrenia and cannabis use disorders since legalization. Dr. Amy Yule will review the evidence for treatment of co-occurring cannabis use disorders and psychotic spectrum disorders with a focus on treatment program adaptations to address social and health inequities. Dr. Elizabeth Thiele will review the evidence for therapeutic indications for cannabinoids to treat neurologic conditions. Lastly, Dr. Yaron Finkelstein will review the clinical manifestations and outcomes of children poisoned by cannabis products before and after legalization.

Learning Objectives:

  • Attendees will be able to discuss the population level associations between cannabis use and structural brain changes.
  • Attendees will be able to describe the key components of treatment for youth with co-occurring cannabis use disorders and psychotic spectrum disorders.
  • Attendees will be able to describe the clinical manifestations and outcomes of children poisoned by cannabis products.

Presentations:

  • 2:00 PM – 2:15 PM ET
    Population-level relationships between cannabis and adolescent brain health

    Speaker: Patricia Conrod, PhD, Clin Psych – Universite de Montreal Faculty of Medicine

  • 2:15 PM – 2:30 PM ET
    Cannabis and Psychosis: population trends and clinical presentation among youth

    Speaker: Evangelia Lila Amirali, MD, FRCPC, DFAPA, MMGMT (IMHL) (she/her/hers) – CHU Sainte-Justine

  • 2:30 PM – 2:45 PM ET
    Treatment of co-occurring cannabis use disorder and psychotic disorders in the context of social and health inequities.

    Speaker: Amy Yule, MD (she/her/hers) – Boston University School of Medicine

  • 2:45 PM – 3:00 PM ET
    Cannabis poisoning in children

    Speaker: Yaron Finkelstein, MD (he/him/his) – The Hospital for Sick Children

  • 3:00 PM – 3:15 PM ET
    Q & A